您好,欢迎您

【2018 ASCO】中国好声音之复旦大学附属肿瘤医院

2018年04月28日
整理:肿瘤资讯
来源:肿瘤资讯

2018ASCO大会即将到来!今年的ASCO会议上, 复旦大学附属肿瘤医院共有7篇研究入选,其中王华英教授、田文娟博士的一项肿瘤突变负荷与DNA损伤修复和卵巢癌预后相关性的研究将在ASCO大会上口头发言。

Oral Session

王华英.jpg

王华英教授、田文娟博士

复旦大学附属肿瘤医院

  • 标题:Association of high tumor mutation (TMB) with DNA damage repair (DDR) alterations and better prognosis in ovarian cancer.

  • 时间:6月3日 9:45 AM-11:15 AM

  • 地点:S406

Poster Board

曹君

题目:Efficacy of mirtazapine in preventing delayed nausea and vomiting induced by highly emetogenic chemotherapy: An open-label, randomized, multicenter phase III trial.

张剑

题目:Updated survival data and biomarker assessment of the CBCSG006 trial: A randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer.

刘欣

题目:Clinical and pathological analysis of eleven adult patients with inflammatory myofibroblastic tumor.

杨立峰

题目:Predicting treatment outcome of rectal cancer patients underwent neoadjuvant chemoradiotherapy by ctDNA: The potential use of ctDNA monitoring as organ-sparing approach.

陈赟

题目:Final results of a phase 3 study of comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (ESO-Shanghai 1).

季冬梅

题目:A phase I dose escalation study of hPV19, a novel humanized monoclonal antibody against vascular endothelial growth factor (VEGF), in patients with advanced solid tumors refractory to standard therapy. 

以上如有遗漏,请给我们留言!!!

责任编辑:肿瘤资讯-贾老师